BRYN MAWR TRUST Co Has $4.58 Million Stake in Envision Healthcare Corporation (EVHC)
BRYN MAWR TRUST Co lifted its stake in shares of Envision Healthcare Corporation (NYSE:EVHC) by 1.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 73,043 shares of the company’s stock after buying an additional 1,237 shares during the quarter. BRYN MAWR TRUST Co owned approximately 0.06% of Envision Healthcare Corporation worth $4,578,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in EVHC. Profund Advisors LLC boosted its holdings in Envision Healthcare Corporation by 9.8% in the first quarter. Profund Advisors LLC now owns 4,861 shares of the company’s stock valued at $298,000 after purchasing an additional 432 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in Envision Healthcare Corporation by 41.1% in the first quarter. Janney Montgomery Scott LLC now owns 5,252 shares of the company’s stock valued at $322,000 after purchasing an additional 1,530 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in Envision Healthcare Corporation by 60.9% in the first quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after purchasing an additional 1,200 shares in the last quarter. Henderson Group PLC boosted its holdings in Envision Healthcare Corporation by 81.9% in the first quarter. Henderson Group PLC now owns 10,902 shares of the company’s stock valued at $668,000 after purchasing an additional 4,908 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in Envision Healthcare Corporation by 42.6% in the first quarter. US Bancorp DE now owns 26,248 shares of the company’s stock valued at $1,609,000 after purchasing an additional 7,842 shares in the last quarter. 64.75% of the stock is owned by institutional investors and hedge funds.
Envision Healthcare Corporation (EVHC) traded down 6.73% during midday trading on Tuesday, hitting $44.46. The stock had a trading volume of 2,396,724 shares. Envision Healthcare Corporation has a 12-month low of $43.95 and a 12-month high of $74.75. The company’s market cap is $5.21 billion. The company has a 50-day moving average price of $51.73 and a 200-day moving average price of $57.58.
Envision Healthcare Corporation (NYSE:EVHC) last issued its earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.75 by $0.04. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The business’s revenue was up 156.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.34 EPS. Equities analysts anticipate that Envision Healthcare Corporation will post $1.40 EPS for the current year.
In other news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction that occurred on Thursday, June 22nd. The stock was sold at an average price of $60.00, for a total value of $90,000.00. Following the completion of the transaction, the insider now owns 99,363 shares in the company, valued at approximately $5,961,780. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.10% of the stock is currently owned by company insiders.
EVHC has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Envision Healthcare Corporation in a report on Monday, July 24th. BidaskClub raised Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Zacks Investment Research raised Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price target for the company in a report on Tuesday, July 4th. Jefferies Group LLC set a $71.00 price target on Envision Healthcare Corporation and gave the company a “buy” rating in a report on Thursday, August 24th. Finally, Royal Bank Of Canada upped their price target on Envision Healthcare Corporation from $72.00 to $77.00 and gave the company an “outperform” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Envision Healthcare Corporation currently has a consensus rating of “Buy” and a consensus target price of $71.56.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.